糖皮质激素与实体瘤化疗耐药关系的研究现状
摘要
糖皮质激素广泛用于肿瘤的一线治疗或辅助治疗,但有研究发现,糖皮质激素能诱导实体瘤对化疗耐药。本文就糖皮质激素与实体瘤化疗耐药关系的研究现状进行综述。
出处
《中国癌症防治杂志》
CAS
2010年第3期241-243,共3页
CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
参考文献19
-
1Machuca C,Mendoza-Milla C,Córdova E,et al.Dexamethasone protection from TNF-alpha-induced cell death in MCF-7 cells requires NF-kappaB and is independent from AKT[J].BMC Cell Biol,2006,7:9.
-
2Mattern J,Büchler MW,Herr L Cell cycle arrest by glucocorticoids may protect normal tissue and solid tumors from cancer therapy[J].Cancer Bid Ther,2007,6(9):1345-1354.
-
3Vogt A,McDonald PR,Tamewitz A,et al.A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptoeis in dexamethasone-protected cancer cells[J].Mol Cancer Ther,2008,7(2):330-340.
-
4Sumikawa T,Shigeoka Y,Igishi T,et al.Dexamethasone interferes with trastuzumab-induced cell growth inhibition through restoration of AKT activity in BT-474 breast cancer cells[J].Int J Oncol,2008,32(3):683-688.
-
5Wagenblast J,Baghi M,Mürtel S,et al.Does dexamethasone inhibit anticancer activity of cetuximab in squamous cell carcinoma cell lines of the head and neck[J]? Oncol Rep,2009,22(1):171-176.
-
6Honorat M,Mesnier A,Di Pietro A,et al.Dexamethssone down-regulates ABCG2 expression levels in breast cancer cells[J].Biochem Biophya Res Commun,2008,375(3):308-314.
-
7Redondo M,Téllez T,Roldan MJ,et al.Anticluserin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity[J].Breast Cancer Res,2007,9(6):R86.
-
8Wu W,Chaudhuri S,Brickley DR,et el.Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells[J].Cancer Res,2004,64(5):1757-1764.
-
9Zhang C,Beckermann B,Kallifatidis G,et al.Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone,brain,breast,cervix,melanoma and neuroblastoma[J].Int J Oncol,2006,29(5):1295-1301.
-
10Lien HC,Lu YS,Shun CT,et al.Differential expression of glucocoticoid receptor in carcinomas of the human digestive system[J].Histopathology,2008,52(3):314-324.
二级参考文献9
-
1The Italian Group of Anticancer Research. Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy[J] . N Engl J Med,2000,342(21) : 1 554.
-
2Herr I, Ucur E, Herzer K, et al. Glucocorticoid cotreatment induces apoptosis resistance toward cancer therapy in carcinomas[J]. Cancer Res ,2003,63(12) :3 112.
-
3Zhang C, Marme A, Wenger T, et al. Glucocorticoid-mediated inhibition of chemotherapy in ovarian carcinomas [ J ]. Int J Oncol,2006,28(2) :551 .
-
4Zhang C, Beckermann B, Kallifatidis G, et al. Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma [J]. Int J Oncol,2006,29 (5) : 1 295.
-
5Wang H, Wang Y, Rayburn ER, et al. Dexamethasone as a chemosensitizer for breast cancer chemotherapy: potentiation of the antltumor activity of adriamycin, modulation of cytokine expression, and pharmacokinetics [ J ]. Int J Oncol, 2007,30 (4) :947.
-
6Schmidt S, Rainer J, Ploner C, et al. Glucocorticoid-induced apoptosis and glucocorticoid resistance:molecular mechanisms and clinical relevance [ J ]. Cell Death Differ, 2004, ( 11 Suppl) :S45.
-
7Herr I, Gassler N, Friess H, et al. Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids [ J ]. Apoptosis ,2007,12(2) :271.
-
8Wu W, Chaudhuri S, Brickley DR. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells [ J ]. Cancer Res ,2004,64(5) : 1 757.
-
9Liu LZ, Zhou XD, Qian G, et al. AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway[J]. Cancer Res ,2007,67(13) :6 325.
-
1谭志军,刘玉莹,李昌生,杨彩云.HMGB1/Bcl-2表达与结直肠癌患者化疗耐药及预后关系的研究[J].中华结直肠疾病电子杂志,2016,5(2):153-158. 被引量:2
-
2田文娴,李芳,岳银艳,周璐,黄亚辉,王静.HMGB1调节自噬诱导肿瘤细胞化疗耐药的研究进展[J].河南医学研究,2016,25(2):256-258. 被引量:3
-
3梁梦(综述),周英琼(审校).谷胱甘肽转移酶-π-与卵巢癌化疗耐药的关系[J].国际肿瘤学杂志,2010,37(3):225-227. 被引量:3
-
4张建好,韩延敏.卵巢上皮性癌患者血浆溶血磷脂酸测定[J].郑州大学学报(医学版),2010,45(5):867-868. 被引量:2
-
5王福安,龚富山,杨淑改,李惠翔.胸苷磷酸化酶与肿瘤关系的研究进展[J].实用心脑肺血管病杂志,2010,18(12):1914-1917. 被引量:1
-
6徐妍,周彩存.细胞外基质与肺癌的细胞凋亡及耐药的关系[J].国际呼吸杂志,2006,26(9):678-680. 被引量:1
-
7崔景英,冉学红,夏柄森,任翠爱,王宝宏.HAG方案治疗老年急性髓细胞白血病疗效分析[J].中国实用医药,2008,3(20):88-89. 被引量:1
-
8历雪莹,朱丽霞,叶琇锦.DNA甲基化及其靶向治疗在急性髓系白血病中的研究进展[J].浙江大学学报(医学版),2016,45(4):387-394. 被引量:3
-
9侯淑玲,乔丽娟,张巧花,李喜,赵志强,黄云鹏.淋巴瘤细胞膜P糖蛋白、信号转导与转录激活因子3及bcl-2表达水平与化疗耐药的相关性[J].白血病.淋巴瘤,2009,18(12):732-734. 被引量:3
-
10王瑞斐,孙京栋,史长青,刘杰.TCMP方案治疗对常规化疗耐药的复发转移性乳腺癌[J].临床肿瘤学杂志,1998,3(3):16-18. 被引量:1